• Pages
01 Welcome
02 Value Proposition
03 Methodology & Tools
04 Credentials
05 Thought Leadership

Private Equity Roll-up Activation Pack

Global Health Industries Big Bet

2023

Work in Progress

With our global deals capabilities we are able to support our clients with any transaction - Pharma Lifescience (PLS) and Healthcare Services (HCS) M&A.

Our extensive portfolio of industry-focused deals services starting from the first strategic considerations and scoping of a target to the intense planning phase between Signing and Closing, to the first 100 days of supporting the integration.

Especially when planning transactions in the highly regulated and thus complex environment our digital tools help us along the deal cycle and make processes more efficient by e.g., automating planning and aligning regulatory and production timelines.

With our PE Roll-up expertise we accommodate the requirements of routined deal maker clients to create scalable platforms that drive value creation when following their buy-&-build strategy.

Savvy health industry dealmakers who can navigate a tricky regulatory and macroeconomic landscape will continue to use M&A to innovate, grow in line with enterprise priorities and implement strategic portfolio measures. This way, they will stay ahead of their competitors.

Christian K. Moldt

Global Health Industries Deals Leader, Partner, PwC Germany


Your Health Industries Private Equity Experts

Stijn Spitaels

Big Bet Expert Private Equity Roll-Up EMEA

stijn.spitaels@pwc.com

+31 6 48452186


Our Health Industries Deals European team consisting of subject matter experts is a true x-Territory and x-LoS effort

Rutger Koning

rutger.koning@pwc.com

+31 6 22009320

Jaymal Patel

jaymal.patel@pwc.com

+44 7841 566876

Wissam Iskandar

iskandar.wissam@pwc.com

+33 1 56 57 48 69

Miguel Contreras Tamayo

miguel_adolfo.contreras.tamayo@pwc.com

+34 680 73 35 67

Roberta Carter

roberta.w.carter@pwc.com

+44 7710 036054

Alex Haenen

alex.haenen@pwc.com

+ 31 6 83608321

Fabrizio Franco

fabrizio.franco@pwc.com

+39 348 528 8714

Ignacio Cañal Illueca

Ignacio.canal.illueca@pwc.com

+34 646 83 70 48

Fiona Webb

fiona.c.webb@pwc.com

+44 7809 756077

Jonathan Williams

jonathan.williams@pwc.com

+44 7595 610363

Marcus Bauer

marcus.bauer@pwc.com

+49 170 2238834

Claudia Frattini

claudia.frattini@pwc.com

+39 346 008 5342

Thomas Krantz

thomas.krantz@pwc.com

+45 39 45 31 40

Benjamin Bredero

Benjamin.bredero@pwc.ch

Anne-Lise Glauser

anne-lise.glauser@pwc.com

+33 6 48098824

Philip Sommer

philip.sommer@pwc.ch

+41 58 792 75 28

Nichlas Jakobsen

nichlas.t.jakobsen@pwc.com

+45 39 45 91 24


Conversation starters

Market trends

Historically, financial value creation for investors was relatively easy, driven by multiple expansion: buying cheap (~5x for a small practice with <3 chairs) and selling a chain for a much higher multiple (~10-15x).

As it (1) becomes harder to find small clinics willing to sell, (2) chains combine into even larger chains, and (3) inflation limits expansion, realizing operational value creation is more important.

To harvest deal volumes above the terminal value in your business, a compelling value creation story and a smooth integration not endangering business continuity remains key.

Health Industries

Health Industries services are under pressure with increasing demand and scientific and technological innovation driving cost increases. Consolidation and business model innovation could drive efficiencies and unlock capacity and trapped value.

Although consolidation across Health Industries services is accelerating, overall level of consolidation is still relatively low and differs across subsectors. One subsector where we at PwC see a strong wave of consolidation is in Dentistry, mostly in domestic deals driven by PE-investors.

The premise of dental consolidation is to create scalable platforms that drive value creation for dentists, patients and investors alike.

PwC comments

We are observing value creation plans often yield mixed results due to practical challenges. Exemplary issues are an excessive focus on growth and acquisitions at the expense of site integration, a decline in dentist/staff engagement, and limited retention of dental professionals.

While achieving the perfect balance may seem challenging, we at PwC have developed a range of best practices for value creation initiatives that drive success in healthcare roll-up strategies.


Learn more about the other Big Bets

Integration

Find out

PE Roll-up

Find out

Digital tools

Find out

Divestiture

Find out

© 2023 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.

Christian Moldt

Client Relationship Partner BioNTech


Dear Team,

Hey, you just created a text paragraph! Somebody once said that the pen is mightier than the sword — and that was in 1839. Just imagine, with the power of cutting-edge content experiences and the ability to distribute your content around the world in mere seconds, writing this paragraph could be one of the most influential things you ever do!

Hey, you just created a text paragraph! Somebody once said that the pen is mightier than the sword — and that was in 1839. Just imagine, with the power of cutting-edge content experiences and the ability to distribute your content around the world in mere seconds, writing this paragraph could be one of the most influential things you ever do!


Contents

Big Bets
Thought Leadership
Contacts